Agios Pharmaceuticals: Q3 Earnings Insights

Agios Pharmaceuticals: Q3 Earnings Insights

Agios Pharmaceuticals AGIO reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.


Agios Pharmaceuticals beat estimated earnings by 15.34%, reporting an EPS of $-1.49 versus an estimate of $-1.76.

Revenue was up $3.52 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.07 which was followed by a 3.95% increase in the share price the next day.

Here's a look at Agios Pharmaceuticals's past performance:


Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate -1.75 -1.81 -1.69 -1.59
EPS Actual -1.68 -1.74 -1.74 -1.56
Revenue Estimate 2.42M 2.71M 560K 2.60M
Revenue Actual 5.58M 832K 0 0

To track all earnings releases for Agios Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-RecapsEarnings